These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 18326736

  • 21. The role of intravitreal bevacizumab in experimental posterior penetrating eye injury.
    Mehdizadeh M, Fattahi F, Eghtedari M, Nowroozzadeh MH, Toosi F.
    Retina; 2011 Jan; 31(1):154-60. PubMed ID: 20838359
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The relation between bevacizumab injection and the formation of subretinal fibrosis in diabetic patients with panretinal photocoagulation.
    Batman C, Ozdamar Y.
    Ophthalmic Surg Lasers Imaging; 2010 Jan; 41(2):190-5. PubMed ID: 20307036
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Testing toxicity of multiple intravitreal injections of bevacizumab in rabbit eyes.
    Xu W, Wang H, Wang F, Jiang Y, Zhang X, Wang W, Qian J, Xu X, Sun X.
    Can J Ophthalmol; 2010 Aug; 45(4):386-92. PubMed ID: 20648082
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Aqueous humor concentration of bevacizumab after subconjunctival injection in rabbit.
    Kim MJ, Han ES, Kim J, Kim TW.
    J Ocul Pharmacol Ther; 2010 Feb; 26(1):49-53. PubMed ID: 20148650
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits.
    Gaudreault J, Fei D, Beyer JC, Ryan A, Rangell L, Shiu V, Damico LA.
    Retina; 2007 Feb; 27(9):1260-6. PubMed ID: 18046235
    [Abstract] [Full Text] [Related]

  • 32. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
    Ramasubramanian A, Shields CL.
    Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
    [Abstract] [Full Text] [Related]

  • 33. Histology of fibrovascular membranes of proliferative diabetic retinopathy after intravitreal injection of bevacizumab.
    Kubota T, Morita H, Tou N, Nitta N, Tawara A, Satoh H, Shimajiri S.
    Retina; 2010 Mar; 30(3):468-72. PubMed ID: 19952991
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Serum concentration of bevacizumab after intravitreal injection in experimental branch retinal vein occlusion.
    Chuang LH, Wu WC, Yeung L, Wang NK, Hwang YS, Chen KJ, Kuo JZ, Lai CC.
    Ophthalmic Res; 2011 Mar; 45(1):31-5. PubMed ID: 20714188
    [Abstract] [Full Text] [Related]

  • 38. Effect of intravitreal injection of high-dose bevacizumab in monkey eyes.
    Sakurai K, Akiyama H, Shimoda Y, Yoshida I, Kurabayashi M, Kishi S.
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4905-16. PubMed ID: 19407010
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Concentrations of unbound bevacizumab in the aqueous of untreated fellow eyes after a single intravitreal injection in humans.
    Meyer CH, Krohne TU, Holz FG.
    Acta Ophthalmol; 2012 Feb; 90(1):68-70. PubMed ID: 20163369
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.